Sodium Sulfacetamide 10 Sulfur 5 Cleanser

SODIUM SULFACETAMIDE 10 SULFUR 5 CLEANSER- sulfacetamide sodium and sulfur rinse
Stratus Pharmaceuticals

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Rx only


Each gram of SODIUM SULFACETAMIDE 10% and SULFUR 5% CLEANSER contains ACTIVES: sodium sulfacetamide 10% (100mg) and sulfur 5% (50 mg) in a cleanser base of INACTIVES: butylated hydroxytoluene, disodium EDTA, disodium laureth sulfosuccinate and disodium lauryl sulfoacetate, emulsifying wax, hydrochloric acid, methyl paraben, mineral oil, PPG-hydroxyethyl coco isostearamide, propyl paraben, purified water, sodium cocoyl isethionate and sodium thiosulfate

Sodium Sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically, Sodium Sulfacetamide is N-{(4-aminophenyl)sulfony}-acetamide, monosodium salt, monohydrate.

The structural formula is:

Chemical Structure
(click image for full-size original)


The most widely accepted mechanism of action of sulfonamides in the Woods-Fildes theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, Sodium Sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours.

The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

Sodium Sulfacetamide 10 Sulfur 5 Cleanser Indications and Usage

SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.


SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER is not to be used by patients with kidney disease.


Although rare, sensitivity to Sodium Sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved. FOR EXTERNAL USE ONLY. Keep out of reach of children. Keep bottle tightly closed.



If irritation develops, use of this product should be discontinued and appropriate therapy instituted. Patients should be very carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy i s to achieve desquamation without irritation, but Sodium Sulfacetamide and Sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

Carcinogenesis, Mutagenesis and Impairment of Fertility

Long-term studies in animals have not been performed to evaluate carcinogenic potential.


Category C

Animal reproduction studies have not been conducted with SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER. It is also not known whether SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER should be given to a pregnant woman only if clearly needed.

Nursing Mothers

It is not known whether Sodium Sulfacetamide is excreted in human milk following topical use of SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when SODIUM SULFACETAMIDE 10% AND SULFUR 5% CLEANSER is administered to a nursing woman.

Pediatric Use

Safety and effectiveness in children under the age of 12 has not been established.

Adverse Reactions to Sodium Sulfacetamide 10 Sulfur 5 Cleanser

Although rare, sodium sulfacetamide may cause local irritation.


Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and liberally apply to areas to be treated, massage gently into skin for 10-20 seconds working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing wash off sooner or using less often.



6 oz. (170.3g) bottles — NDC 58980-340-61
12 oz. (340.2g) bottles — NDC 58980-340-85


Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F), however such exposure should be minimized. Protect from freezing.

Distributed by STRATUS

Manufactured by
Sonar Products, Inc.
Carlstadt, NJ 07072
Stratus Pharmaceuticals Inc.
12379 Southwest 130th Street
Miami, Florida 33186-6727

Customer Service
Telephone: 1-800-442-7882
Fax: 305-254-6875

©2011 Stratus Pharmaceuticals Inc.

Rev. SSSC-IN2011-343.

PRINCIPAL DISPLAY PANEL — 170.3 g Bottle Label

NDC 58980-340-61



Rx only


Net WT. 6 OZ (170.3 g)

PRINCIPAL DISPLAY PANEL -- 170.3 g Bottle Label
(click image for full-size original)
sulfacetamide sodium and sulfur rinse
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:58980-340
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Sulfacetamide Sodium (Sulfacetamide) Sulfacetamide Sodium 10 mg in 1 g
Sulfur (Sulfur) Sulfur 5 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
Butylated Hydroxytoluene
Edetate Disodium
Disodium Laureth Sulfosuccinate
Sodium Lauryl Sulfoacetate
Hydrochloric Acid
Mineral Oil
Sodium Cocoyl Isethionate
Sodium Thiosulfate
Product Characteristics
Color YELLOW Score
Shape Size
Flavor Imprint Code
# Item Code Package Description Multilevel Packaging
1 NDC:58980-340-85 1 BOTTLE (BOTTLE) in 1 BOX contains a BOTTLE
1 340.2 g in 1 BOTTLE This package is contained within the BOX (58980-340-85)
2 NDC:58980-340-61 1 BOTTLE (BOTTLE) in 1 BOX contains a BOTTLE
2 170.3 g in 1 BOTTLE This package is contained within the BOX (58980-340-61)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Labeler — Stratus Pharmaceuticals (789001641)
Registrant — Sonar Products, Inc (104283945)
Name Address ID/FEI Operations
Sonar Products, Inc 104283945 MANUFACTURE (58980-340)

Revised: 04/2012 Stratus Pharmaceuticals

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.